These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 18281485)

  • 21. Soluble vascular endothelial growth factor receptor-3 suppresses lymphangiogenesis and lymphatic metastasis in bladder cancer.
    Yang H; Kim C; Kim MJ; Schwendener RA; Alitalo K; Heston W; Kim I; Kim WJ; Koh GY
    Mol Cancer; 2011 Apr; 10():36. PubMed ID: 21481239
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lymphangiogenesis in chronic inflammation in the testis.
    Hirai S; Naito M; Terayama H; Qu N; Kuerban M; Musha M; Itoh M
    Andrology; 2013 Jan; 1(1):147-54. PubMed ID: 23258644
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lymphangiogenesis in aortic valve stenosis--novel regulatory roles for valvular myofibroblasts and mast cells.
    Syväranta S; Helske S; Lappalainen J; Kupari M; Kovanen PT
    Atherosclerosis; 2012 Apr; 221(2):366-74. PubMed ID: 22281299
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Soluble FLT-1 expression suppresses carcinomatous ascites in nude mice bearing ovarian cancer.
    Hasumi Y; Mizukami H; Urabe M; Kohno T; Takeuchi K; Kume A; Momoeda M; Yoshikawa H; Tsuruo T; Shibuya M; Taketani Y; Ozawa K
    Cancer Res; 2002 Apr; 62(7):2019-23. PubMed ID: 11929819
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lymphangiogenesis and its relationship with lymphatic metastasis and prognosis in malignant melanoma.
    Liu B; Ma J; Wang X; Su F; Li X; Yang S; Ma W; Zhang Y
    Anat Rec (Hoboken); 2008 Oct; 291(10):1227-35. PubMed ID: 18561194
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of lymphangiogenesis and lymphangiogenic factors during pancreatic cancer progression and lymphatic spread.
    Schneider M; Büchler P; Giese N; Giese T; Wilting J; Büchler MW; Friess H
    Int J Oncol; 2006 Apr; 28(4):883-90. PubMed ID: 16525637
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pathogenesis of ascites tumor growth: angiogenesis, vascular remodeling, and stroma formation in the peritoneal lining.
    Nagy JA; Morgan ES; Herzberg KT; Manseau EJ; Dvorak AM; Dvorak HF
    Cancer Res; 1995 Jan; 55(2):376-85. PubMed ID: 7529135
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tumour expression of lymphangiogenic growth factors but not lymphatic vessel density is implicated in human cervical cancer progression.
    Sotiropoulou N; Bravou V; Kounelis S; Damaskou V; Papaspirou E; Papadaki H
    Pathology; 2010 Dec; 42(7):629-36. PubMed ID: 21080871
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vascular endothelial growth factor D is dispensable for development of the lymphatic system.
    Baldwin ME; Halford MM; Roufail S; Williams RA; Hibbs ML; Grail D; Kubo H; Stacker SA; Achen MG
    Mol Cell Biol; 2005 Mar; 25(6):2441-9. PubMed ID: 15743836
    [TBL] [Abstract][Full Text] [Related]  

  • 30. LYVE-1-positive macrophages are present in normal murine eyes.
    Xu H; Chen M; Reid DM; Forrester JV
    Invest Ophthalmol Vis Sci; 2007 May; 48(5):2162-71. PubMed ID: 17460275
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of VEGFR-3 and 5'-nase in regenerating lymphatic vessels of the cutaneous wound healing.
    Ji RC; Miura M; Qu P; Kato S
    Microsc Res Tech; 2004 Jun; 64(3):279-86. PubMed ID: 15452895
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumor-secreted vascular endothelial growth factor-C is necessary for prostate cancer lymphangiogenesis, but lymphangiogenesis is unnecessary for lymph node metastasis.
    Wong SY; Haack H; Crowley D; Barry M; Bronson RT; Hynes RO
    Cancer Res; 2005 Nov; 65(21):9789-98. PubMed ID: 16267000
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Signalling via vascular endothelial growth factor receptor-3 is sufficient for lymphangiogenesis in transgenic mice.
    Veikkola T; Jussila L; Makinen T; Karpanen T; Jeltsch M; Petrova TV; Kubo H; Thurston G; McDonald DM; Achen MG; Stacker SA; Alitalo K
    EMBO J; 2001 Mar; 20(6):1223-31. PubMed ID: 11250889
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Spreds are essential for embryonic lymphangiogenesis by regulating vascular endothelial growth factor receptor 3 signaling.
    Taniguchi K; Kohno R; Ayada T; Kato R; Ichiyama K; Morisada T; Oike Y; Yonemitsu Y; Maehara Y; Yoshimura A
    Mol Cell Biol; 2007 Jun; 27(12):4541-50. PubMed ID: 17438136
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Erythropoietin induces lymph node lymphangiogenesis and lymph node tumor metastasis.
    Lee AS; Kim DH; Lee JE; Jung YJ; Kang KP; Lee S; Park SK; Kwak JY; Lee SY; Lim ST; Sung MJ; Yoon SR; Kim W
    Cancer Res; 2011 Jul; 71(13):4506-17. PubMed ID: 21586615
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endothelin-1 stimulates lymphatic endothelial cells and lymphatic vessels to grow and invade.
    Spinella F; Garrafa E; Di Castro V; Rosanò L; Nicotra MR; Caruso A; Natali PG; Bagnato A
    Cancer Res; 2009 Mar; 69(6):2669-76. PubMed ID: 19276384
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative evaluation of FGF-2-, VEGF-A-, and VEGF-C-induced angiogenesis, lymphangiogenesis, vascular fenestrations, and permeability.
    Cao R; Eriksson A; Kubo H; Alitalo K; Cao Y; Thyberg J
    Circ Res; 2004 Mar; 94(5):664-70. PubMed ID: 14739162
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Remodeling of the lymphatic vasculature during mouse mammary gland morphogenesis is mediated via epithelial-derived lymphangiogenic stimuli.
    Betterman KL; Paquet-Fifield S; Asselin-Labat ML; Visvader JE; Butler LM; Stacker SA; Achen MG; Harvey NL
    Am J Pathol; 2012 Dec; 181(6):2225-38. PubMed ID: 23063660
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting lymphatic vessel activation and CCL21 production by vascular endothelial growth factor receptor-3 inhibition has novel immunomodulatory and antiarteriosclerotic effects in cardiac allografts.
    Nykänen AI; Sandelin H; Krebs R; Keränen MA; Tuuminen R; Kärpänen T; Wu Y; Pytowski B; Koskinen PK; Ylä-Herttuala S; Alitalo K; Lemström KB
    Circulation; 2010 Mar; 121(12):1413-22. PubMed ID: 20231530
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Expression of vascular endothelial growth factors (VEGF)-A, -C and -D and their prognostic significance and relationship with angio- and lymphangiogenesis in gastric cancer].
    Wang XL; Ai ZS; Fang JP; Tang RY; Chen XM
    Zhonghua Zhong Liu Za Zhi; 2008 Nov; 30(11):837-43. PubMed ID: 19173829
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.